AusPAR: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat

Australian Public Assessment Report

AusPAR

AusPAR: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [PDF, 1.3 MB]

AusPAR: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [Word, 1.82 MB]

Attachment: Product Information: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [PDF, 366.19 KB]

Attachment: Product Information: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [Word, 168.91 KB]

Attachment: Extract from Clinical Evaluation Report: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [PDF, 4.67 MB]

Attachment: Extract from Clinical Evaluation Report: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [Word, 4.2 MB]

Device/Product Name

Stribild

Active ingredients

Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat

AusPAR Date

1 June 2017

Published

7 June 2017

Submission Number

PM-2014-01079-1-2

Submission Type

Extension of indications

Decision

Approved